Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002056296-25-000001
Filing Date
2025-02-20
Accepted
2025-02-20 07:53:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3111
  Complete submission text file 0002056296-25-000001.txt   4713
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190840
BioNTech SE (Subject) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39081 | Film No.: 25643315
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address PHILIPP-VON-ZABERN-PLATZ 1 MAINZ 2M D-55116
Business Address PHILIPP-VON-ZABERN-PLATZ 1 MAINZ 2M D-55116 49-6131-9084-0
Medine GmbH (Reporting) CIK: 0001803150 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 144